Aspire Biopharma Holdings, Inc. 10-Q filing
Filed 2025-11-14 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001493152-25-022595
- Form type
- 10-Q
- CIK
- 0001847345
- Primary document
- https://www.sec.gov/Archives/edgar/data/1847345/000149315225022595/form10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aspire Biopharma Holdings, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Cost Of Revenue | $1,057 | - | - |
| Gross Profit | $884 | - | - |
| Operating Income | $-17.5M | - | - |
| Net Income | $-19.8M | - | - |
| Eps Basic | -0.43 | - | - |
| Eps Diluted | -0.43 | - | - |
| Total Assets | $2.4M | - | - |
| Total Liabilities | $13.9M | - | - |
| Shareholders Equity | $-11.5M | - | - |
| Operating Cash Flow | $-4.0M | - | - |